Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

NeuroSync Auditory-Cognitive Training for Listening in Noise in Hearing Aid Users

11. November 2026 aktualisiert von: Busra Nur Eser, Medipol University

Improving and Evaluating Listening-in-Noise Performance in Hearing Aid Users

The goal of this clinical trial is to learn whether NeuroSync (Turkish: Nörosenkron), a 6-week, home-based, web-delivered auditory-cognitive training program, improves listening in noise in adults aged 18 to 65 years who use hearing aids in both ears for sensorineural hearing loss.

The main questions it aims to answer are:

  • Does NeuroSync training improve speech understanding in noise, measured with the Turkish Hearing in Noise Test (HINT)?
  • Does NeuroSync training reduce listening effort, measured with a dual-task test?

Researchers will compare NeuroSync training with an active control condition (watching "how-to" videos on the same web platform) to see whether the training leads to greater improvement.

Participants will:

  • Be assigned by chance to the NeuroSync training group or the video (active control) group
  • Complete 4 sessions per week for 6 weeks at home (24 sessions, each up to 30 minutes), while continuing their usual daily hearing aid use
  • Visit their hearing aid center before and after the 6-week period for hearing, listening-in-noise, and listening-effort tests and a questionnaire

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

This is a multicenter, randomized, active-controlled, parallel-group trial with pre-test (T0) and post-test (T1) assessments. Adult bilateral hearing aid users are recruited from five hearing aid centers in collaboration with the Department of Audiology, Istanbul Medipol University.

After eligibility screening, written informed consent, and the baseline (T0) assessment, participants are randomized 1:1 to the NeuroSync training arm or the active control arm. Randomization is stratified by center, using computer-generated variable-size blocks. The allocation sequence is prepared and held by an independent person who is not involved in enrollment, training, or outcome assessment, and the allocation for each participant is disclosed only after T0 is complete. The trial is open label: participants, the team delivering the training, and the outcome assessor are aware of group assignment. In the HINT and the dual-task test, each response is scored by the assessor in view of the participant, and thresholds, reaction times, and medians are calculated by the test software.

NeuroSync is a Turkish-language, web-based program delivered at home (4 sessions per week for 6 weeks; 24 sessions; up to 30 minutes each). Sessions combine a music/rhythm warm-up, speech-in-noise listening tasks, working-memory and attention exercises, and a short narrative with comprehension questions. Content follows weekly daily-life themes, and difficulty increases gradually across the six weeks. Session completion and task performance are logged by the platform.

Participants in the active control arm continue routine hearing aid use and watch "how-to" videos on the same web platform, using individual log-in accounts so that viewing can be verified, on the same schedule and for the same session duration as the training arm. They receive no graded signal-to-noise ratio training, music-based or cognitive exercises, dual tasks, or performance feedback. Access to NeuroSync is offered to control participants after the study ends.

All assessments are performed at the centers with participants wearing their own bilateral hearing aids in their everyday program. The baseline (T0) assessment is completed within about 10 days before the intervention period, and the post-test (T1) assessment within about 10 days after the end of the 6-week period. The test order is SSQ12, HINT, dual-task listening-effort test, SMRT, and random gap detection test.

A minimum of 34 participants is required (repeated-measures within-between interaction, effect size f = 0.25, alpha = 0.05, power = 0.80); 40 participants (20 per arm) will be enrolled to allow for attrition. The primary outcome will be analyzed with a linear mixed model (group, time, and group-by-time interaction) following the intention-to-treat principle.

Studientyp

Interventionell

Einschreibung (Geschätzt)

40

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

      • Istanbul, Türkei (türkiye)
        • Caddebostan Meta Ses İşitme Merkezi
      • Istanbul, Türkei (türkiye)
        • Fenerbahçe Luna İşitme Merkezi
      • Istanbul, Türkei (türkiye)
        • Nispetiye Luna İşitme Merkezi
      • Istanbul, Türkei (türkiye)
        • NOVA İşitme Cihazları Satış ve Uygulama Merkezi
      • Istanbul, Türkei (türkiye)
        • Şişli Meta Ses İşitme Merkezi

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 65 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Age 18 to 65 years
  • Bilateral, symmetric sensorineural hearing loss of mild, moderate, or moderately severe degree
  • Bilateral use of receiver-in-canal (RIC/RITE) or behind-the-ear (BTE) hearing aids
  • Bilateral hearing aid use for at least 3 months and at least 8 hours per day, verified by hearing aid data logging
  • Speech discrimination score of at least 52% in each ear
  • Standardized Mini-Mental State Examination score of at least 24
  • Native speaker of Turkish
  • Normal or corrected-to-normal visual acuity and normal color vision, sufficient to perform the color-based visual task
  • Basic ability to use the internet and a computer or tablet

Exclusion Criteria:

  • Unilateral or markedly asymmetric hearing loss
  • Conductive or mixed hearing loss, or active middle ear pathology
  • Cochlear implant use
  • Significant neurological disease or diagnosed cognitive impairment that could affect test performance
  • Uncontrolled psychiatric condition that could markedly affect participation in testing
  • Visual, motor, or communication impairment that prevents administration of the tests
  • Previous participation in a structured auditory and/or cognitive training program
  • Professional music training or current or past work as a professional musician

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Unterstützende Pflege
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: NeuroSync Auditory-Cognitive Training

Participants complete the NeuroSync (Nörosenkron) web-based auditory-cognitive training program at home: 4 sessions per week for 6 weeks (24 sessions, up to 30 minutes each), while continuing routine daily use of their own bilateral hearing aids (at least 8 hours per day).

Turkish-language, home-based, web-delivered auditory-cognitive training: 4 sessions per week for 6 weeks (24 sessions, up to 30 minutes each). Each session combines a music/rhythm warm-up, speech-in-noise listening and comprehension tasks, working-memory, attention and dual-task exercises, and a short narrative with comprehension questions. Content follows weekly daily-life themes. Difficulty increases progressively across the six weeks: the signal-to-noise ratio of the speech-in-noise tasks becomes less favorable and the musical and cognitive demands increase. Task-specific feedback is given. Session completion, accuracy, and reaction times are logged by the platform.

Andere Namen:
  • Nörosenkron
Aktiver Komparator: Active Control: How-To Videos

Participants continue routine daily use of their own bilateral hearing aids (at least 8 hours per day) and watch "how-to" videos on the same web platform, with individual log-in accounts so that viewing is verified: 4 sessions per week for 6 weeks, matched in session duration to the training arm. No graded speech-in-noise training, music-based or cognitive exercises, dual tasks, or performance feedback are provided.

Participants watch "how-to" videos delivered through the same web platform as the training program, using individual user name and password log-in so that viewing can be verified: 4 sessions per week for 6 weeks, with the same session duration as the training arm. The condition is intended to balance study participation, exposure to auditory content, and researcher attention. It includes no graded signal-to-noise ratio training, music-based or cognitive exercises, dual tasks, or performance feedback. Participants continue routine daily hearing aid use.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Speech Reception Threshold in Noise on the Turkish Hearing in Noise Test (HINT)
Zeitfenster: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Adaptive signal-to-noise ratio (dB SNR) at which 50% of sentences are correctly recognized on the Turkish HINT. Tested in the sound field in a sound-treated booth with participants wearing their own bilateral hearing aids in their everyday program; speech and noise are presented from the same loudspeaker at 0 degrees azimuth, 1 m (S0N0), with noise fixed at 65 dB. Different sentence lists are used at T0 and T1. Change is calculated as T1 minus T0. Lower thresholds (a decrease) indicate better speech understanding in noise.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Dual-Task Cost 3 dB Below the HINT Threshold SNR
Zeitfenster: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Dual-task cost (DTC) is the percent change in median secondary-task reaction time in the dual-task condition relative to the single-task (visual task alone) condition: DTC (%) = [(dual-task median RT - single-task median RT) / single-task median RT] x 100. The dual-task condition presents Turkish Matrix Test sentences in noise at a signal-to-noise ratio 3 dB below (less favorable than) the participant's HINT threshold measured on the same day. Change is calculated as T1 minus T0 (percentage points). Lower values (a decrease) indicate less listening effort.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Dual-Task Cost at the HINT Threshold SNR
Zeitfenster: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Dual-task cost (DTC) is the percent change in median secondary-task reaction time in the dual-task condition relative to the single-task (visual task alone) condition: DTC (%) = [(dual-task median RT - single-task median RT) / single-task median RT] x 100. The dual-task condition presents Turkish Matrix Test sentences in noise at a signal-to-noise ratio equal to the participant's HINT threshold measured on the same day. Change is calculated as T1 minus T0 (percentage points). Lower values (a decrease) indicate less listening effort.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Dual-Task Cost 3 dB Above the HINT Threshold SNR
Zeitfenster: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Dual-task cost (DTC) is the percent change in median secondary-task reaction time in the dual-task condition relative to the single-task (visual task alone) condition: DTC (%) = [(dual-task median RT - single-task median RT) / single-task median RT] x 100. The dual-task condition presents Turkish Matrix Test sentences in noise at a signal-to-noise ratio 3 dB above (more favorable than) the participant's HINT threshold measured on the same day. Change is calculated as T1 minus T0 (percentage points). Lower values (a decrease) indicate less listening effort.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Speech, Spatial and Qualities of Hearing Scale 12-Item Version (SSQ12) Score
Zeitfenster: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Turkish SSQ12-A, a 12-item self-report questionnaire of everyday hearing ability, answered with reference to everyday listening with bilateral hearing aids. Each item is rated from 0 to 10; the scale score is the mean of the 12 items (range 0 to 10). Change is calculated as T1 minus T0. Higher scores (an increase) indicate better self-perceived hearing ability.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Speech Repetition Accuracy in the Dual-Task Listening-Effort Test
Zeitfenster: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Percentage of trials in which at least 3 of the 5 words of the Turkish Matrix Test sentence are repeated correctly during the dual-task test, reported separately for each of the three signal-to-noise ratio conditions (3 dB below, at, and 3 dB above the HINT threshold). Change is calculated as T1 minus T0 (percentage points). Higher values indicate better performance. Supportive outcome used to interpret the reaction-time measures.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Spectral-Temporally Modulated Ripple Test (SMRT) Threshold
Zeitfenster: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Spectro-temporal resolution threshold in ripples per octave (RPO) measured with SMRT software (three-interval forced-choice, adaptive 1-up/1-down procedure; threshold is the mean of the last six reversals), presented in the sound field at the participant's most comfortable level with bilateral hearing aids. Change is calculated as T1 minus T0. Higher values indicate better discrimination. Exploratory outcome.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Random Gap Detection Thresholds (Turkish RATET)
Zeitfenster: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Shortest inter-stimulus gap in milliseconds at which two tones are perceived as two sounds, measured separately at 500, 1000, 2000, and 4000 Hz with the Turkish random gap detection test (gaps of 0 to 40 ms), presented in the sound field at the most comfortable level with bilateral hearing aids. If two sounds are not perceived at 40 ms, the result is recorded as greater than 40 ms (right-censored). Lower thresholds indicate better temporal resolution. Exploratory outcome.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Participant Satisfaction With the NeuroSync Program
Zeitfenster: Post-test (T1, at the end of the 6-week intervention period)

Five-question satisfaction questionnaire developed by the investigators, administered only to the experimental arm. Responses are reported descriptively as the distribution of answers to each question.

Post-test (T1, at the end of the 6-week intervention period)
Change in Dual-Task Median Reaction Time 3 dB Below the HINT Threshold SNR
Zeitfenster: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Listening effort is assessed with a dual-task paradigm in the sound field with participants wearing their own bilateral hearing aids. Primary task: repetition of Turkish Matrix Test sentences in noise (noise fixed at 65 dB), presented at a signal-to-noise ratio 3 dB below (less favorable than) the participant's HINT threshold measured on the same day. Secondary task: a four-color visual choice reaction-time task (key press). The outcome is the median reaction time in milliseconds for trials with a correct color response and correct speech repetition (at least 3 of 5 words). Change is calculated as T1 minus T0. Lower values (a decrease) indicate less listening effort.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Dual-Task Median Reaction Time at the HINT Threshold SNR
Zeitfenster: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Listening effort is assessed with a dual-task paradigm in the sound field with participants wearing their own bilateral hearing aids. Primary task: repetition of Turkish Matrix Test sentences in noise (noise fixed at 65 dB), presented at a signal-to-noise ratio equal to the participant's HINT threshold measured on the same day. Secondary task: a four-color visual choice reaction-time task (key press). The outcome is the median reaction time in milliseconds for trials with a correct color response and correct speech repetition (at least 3 of 5 words). Change is calculated as T1 minus T0. Lower values (a decrease) indicate less listening effort.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)
Change in Dual-Task Median Reaction Time 3 dB Above the HINT Threshold SNR
Zeitfenster: Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Listening effort is assessed with a dual-task paradigm in the sound field with participants wearing their own bilateral hearing aids. Primary task: repetition of Turkish Matrix Test sentences in noise (noise fixed at 65 dB), presented at a signal-to-noise ratio 3 dB above (more favorable than) the participant's HINT threshold measured on the same day. Secondary task: a four-color visual choice reaction-time task (key press). The outcome is the median reaction time in milliseconds for trials with a correct color response and correct speech repetition (at least 3 of 5 words). Change is calculated as T1 minus T0. Lower values (a decrease) indicate less listening effort.

Baseline (T0, before the intervention) and post-test (T1, at the end of the 6-week intervention period)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Ermittler

  • Studienleiter: M. Bülent Şerbetçioğlu, MD, PhD, Istanbul Medipol University, Department of Audiology

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

16. November 2026

Primärer Abschluss (Geschätzt)

1. Februar 2027

Studienabschluss (Geschätzt)

1. Februar 2027

Studienanmeldedaten

Zuerst eingereicht

11. November 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

11. November 2026

Zuerst gepostet (Tatsächlich)

18. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

18. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

11. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • E-10840098-772.02-2036
  • 2026-72 (Andere Zuschuss-/Finanzierungsnummer: Istanbul Medipol University Scientific Research Projects (BAP) Coordination Unit)

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

Individual participant data will not be deposited in a repository; requests may be considered by the investigators after publication. Any data provided would be coded and would not include names or other direct identifiers.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .